Compare RMNI & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RMNI | XOMA |
|---|---|---|
| Founded | 2005 | 1981 |
| Country | United States | United States |
| Employees | N/A | 13 |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.9M | 308.6M |
| IPO Year | N/A | N/A |
| Metric | RMNI | XOMA |
|---|---|---|
| Price | $3.29 | $25.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $5.50 | ★ $63.25 |
| AVG Volume (30 Days) | 305.5K | ★ 707.5K |
| Earning Date | 02-19-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.47 | ★ 0.82 |
| Revenue | ★ $425,959,000.00 | $47,106,000.00 |
| Revenue This Year | N/A | $77.29 |
| Revenue Next Year | $4.11 | $29.30 |
| P/E Ratio | ★ $6.81 | $30.33 |
| Revenue Growth | N/A | ★ 118.02 |
| 52 Week Low | $2.73 | $18.35 |
| 52 Week High | $5.38 | $39.92 |
| Indicator | RMNI | XOMA |
|---|---|---|
| Relative Strength Index (RSI) | 27.70 | 45.71 |
| Support Level | $3.17 | $24.70 |
| Resistance Level | $3.54 | $27.87 |
| Average True Range (ATR) | 0.13 | 1.51 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 13.39 | 35.87 |
Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The Company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, database, and technology software platforms. The Company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management database, and technology software systems. Geographically, the company generates the majority of its revenue from the United States of America and the International market.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.